Chargement en cours...
The role of proprotein convertase subtilisin-kexin type 9 (PCSK9) in the vascular aging process – is there a link?
Lately there are many new, promising low-density lipoprotein cholesterol reducing therapies with PCSK9 inhibitors. We performed selected sampling of the publications in PubMed and made a review according to selected keywords. It summarizes the effect of PCSK9 on vascular aging, directly associated w...
Enregistré dans:
| Publié dans: | Kardiochir Torakochirurgia Pol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Termedia Publishing House
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6836637/ https://ncbi.nlm.nih.gov/pubmed/31708986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/kitp.2019.88602 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|